NBIX vs SCI
Neurocrine Biosciences Inc (NBIX) versus Service Corporation International (SCI) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Service Corporation International (SCI) is a personal services company listed on NYSE.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SCI revenue for 2025-12-31 was $4.31B. Net income was $542.6M. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
Not investment advice. Open the NBIX and SCI stock pages for the full models.
Not investment advice.